Risk factors and incidence of thrombosis in a Brazilian cohort of patients with Philadelphia-negative myeloproliferative neoplasms-Reference-Cited by-同舟云学术

Risk factors and incidence of thrombosis in a Brazilian cohort of patients with Philadelphia-negative myeloproliferative neoplasms

Published:2020-01-02 Issue:4 Volume:49 Page:667-672
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Seguro Fernanda Salles^ORCID,Teixeira Larissa Lane Cardoso,da Rosa Lidiane Inês,da Silva Wellington Fernandes,Nardinelli Luciana,Bendit Israel,Rocha Vanderson

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s11239-019-02029-y.pdf

Reference28 articles.

1. Gilbert HS, Dameshek W (1970) The myeloproliferative disorders. Dis Month 16:1–52

2. Pikman Y, Lee BH, Mercher T, McDowell E, Ebert BL, Gozo M et al (2006) MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Med 3(7):e270. https://doi.org/10.1371/journal.pmed.0030270

3. Rotunno G, Mannarelli C, Guglielmelli P, Pacilli A, Pancrazzi A, Pieri L et al (2014) Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia. Blood 123(10):1552–1555

4. James C, Ugo V, Le Couédic J-P, Staerk J, Delhommeau F, Lacout C et al (2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434(7037):1144–1148

5. Tefferi A (2007) JAK2 mutations and clinical practice in myeloproliferative neoplasms. Cancer J 13(6):366–371

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for ischemic stroke in patients with Philadelphia chromosome (Ph)–negative myeloproliferative neoplasms;Journal of Clinical Neuroscience;2024-07

2. Overview of dyslipidemia and metabolic syndrome in myeloproliferative neoplasms;World Journal of Clinical Oncology;2024-06-24

3. A Review About the Assessment of the Bleeding and Thrombosis Risk for Patients With Myeloproliferative Neoplasms Scheduled for Surgery;Cureus;2024-03-12

4. Essential thrombocythemia: nutritional management in weight loss and malnutrition;The Pan African Medical Journal;2024

5. Diagnosis and Management of Cardiovascular Risk in Patients with Polycythemia Vera;Vascular Health and Risk Management;2023-11